Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial.
Ma J, Wang J, Xu T, Ouyang Q, Wang X, Wang J, Gan L, Ouyang Z, Lin D, Sun T, Shan C, Yao H, Zhang B, Li Z, Zhuang Z, Lu Y, Yang H, Huang J, Yang X, Sun H, Zhang Q.
Ma J, et al.
Cancer Commun (Lond). 2025 Jan 18. doi: 10.1002/cac2.12662. Online ahead of print.
Cancer Commun (Lond). 2025.
PMID: 39825877